Search results
Results From The WOW.Com Content Network
If a person without a Kidd blood antigen (for example a Jka-Jkb+ patient) receives a Kidd antigen (Jka-antigen for example) in a red blood cell transfusion and forms an alloantibody (anti-Jka); upon subsequent transfusion with Jka-antigen positive red blood cells, the patient may have a delayed hemolytic transfusion reaction as their anti-Jka antibody hemolyzes the transfused Jka-antigen ...
An acute hemolytic transfusion reaction (AHTR), also called immediate hemolytic transfusion reaction, is a life-threatening reaction to receiving a blood transfusion. AHTRs occur within 24 hours of the transfusion and can be triggered by a few milliliters of blood. The reaction is triggered by host antibodies destroying donor red blood cells.
Kidd antibodies are often capable of binding complement and causing intravascular hemolysis. More often, however, Kidd antibodies cause acute extravascular hemolysis. [7] They are a notorious cause of delayed hemolytic transfusion reactions, and may occur up to a week after transfusion in some instances.
Febrile non-hemolytic transfusion reaction (FNHTR) is the most common type of transfusion reaction. It is a benign occurrence with symptoms that include fever but not directly related with hemolysis. [1] It is caused by cytokine release from leukocytes within the donor product as a consequence of white blood cell breakdown.
The severity of the transfusion reaction is depended upon amount of donor's antigen transfused, nature of the donor's antigens, the nature and the amount of recipient antibodies. [36] Delayed hemolytic reactions occur more than 24 hours after a transfusion. They usually occur within 28 days of a transfusion.
TACO and transfusion-related acute lung injury (TRALI) are both complications following a transfusion, and both can result in respiratory distress. [2] TACO and TRALI are often difficult to distinguish in the acute situation. [citation needed] Assessing fluid status is key in differentiating between the two.
Transfusion hemosiderosis; Transfusion-associated circulatory overload; Transfusion-associated graft-versus-host disease; Transfusion-dependent anemia; Transfusion-related acute lung injury; Transfusion-related immunomodulation
Dogs that are DEA 1.1 positive (33 to 45% of the population) are universal recipients - that is, they can receive blood of any type without expectation of a life-threatening hemolytic transfusion reaction. Dogs that are DEA 1.1 negative are universal donors. Blood from DEA 1.1 positive dogs should never be transfused into DEA 1.1 negative dogs.